PMID: 8994239Jan 1, 1997Paper

Venous thromboembolism during pregnancy: a current review of diagnosis and management

Obstetrical & Gynecological Survey
M R Toglia, T E Nolan

Abstract

Pregnancy is widely recognized to be a physiologic state with a markedly elevated risk for thromboembolic complications. The diagnosis and management of venous thromboembolic events during pregnancy, however, remains controversial because of the lack of prospective, randomized trials that have included pregnant women. Significant progress has been made in the last 10 years in the management of these conditions in the nonpregnant patient and strong clinical guidelines have been established recently. Obstetrician-gynecologists may modify these guidelines and apply them to the pregnant patient based on their knowledge of the physiologic changes in pregnancy. Objective diagnostic techniques should be used liberally when the diagnosis of deep vein thrombosis or pulmonary emboli is considered because early intervention may prevent serious maternal sequelae including death. Heparin remains the anticoagulant of choice during pregnancy because of its proven safety for both the patient and the fetus. It is likely that long-term anticoagulation is necessary when venous thromboembolism occurs antepartum, although the most efficacious regimen has yet to be established. There is some concern about the prolonged use of heparin during pregnanc...Continue Reading

References

Oct 23, 1976·Lancet·W HolzgreveB D Hall
Apr 1, 1979·American Journal of Surgery·J O Menzoian, L F Williams
Sep 1, 1976·Thrombosis Research·D P ThomasV V Kakkar
Jan 15, 1977·American Journal of Obstetrics and Gynecology·W L Shaul, J G Hall
Mar 1, 1977·The American Journal of Medicine·W R BellD L DeMets
Jun 18, 1977·British Medical Journal·M L OrmeA M Breckenridge
Dec 1, 1992·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·S GillisA Eldor
Aug 1, 1992·Archives of Surgery·L J GreenfieldJ Wingo
Feb 1, 1991·Archives of Internal Medicine·M K CruickshankM Siguenza
Feb 1, 1991·Práctica odontológica
Sep 1, 1991·American Journal of Obstetrics and Gynecology·J F Polak, D L Wilkinson
May 30, 1991·The New England Journal of Medicine·J Hirsh
Jan 1, 1990·Acta Obstetricia Et Gynecologica Scandinavica·B FagherB Astedt
Mar 1, 1990·British Journal of Obstetrics and Gynaecology·T DahlmanM Hellgren
Jun 1, 1990·American Journal of Public Health·A L FranksK S Colberg
Feb 9, 1989·The New England Journal of Medicine·A W LensingH R Büller
Feb 1, 1989·Chest·J S Ginsberg, J Hirsh
Aug 15, 1989·Annals of Internal Medicine·R H WhiteR P Hartling
Aug 1, 1989·American Journal of Obstetrics and Gynecology·T C DahlmanM Blombäck
Oct 1, 1989·Archives of Internal Medicine·J S GinsbergR Burrows
Aug 8, 1986·JAMA : the Journal of the American Medical Association
Mar 1, 1985·Clinical Obstetrics and Gynecology·C P Weiner
Apr 1, 1973·Pennsylvania Medicine·D Naide, M Naide
Oct 25, 1969·British Medical Journal·C K AngC Wood
Apr 15, 1971·American Journal of Obstetrics and Gynecology·L A Aaro, J L Juergens
Oct 5, 1968·British Medical Journal·T N JeffcoateV R Tindall
Apr 1, 1984·Annals of Internal Medicine·D J King, J G Kelton
Dec 1, 1983·British Journal of Obstetrics and Gynaecology·M de SwietP H Wise
Jan 1, 1983·Acta Obstetricia Et Gynecologica Scandinavica·A BergqvistT Hallböök
Jan 1, 1983·Acta Obstetricia Et Gynecologica Scandinavica·D Bergqvist, U Hedner
Jan 1, 1980·The American Journal of Medicine·J G HallK M Wilson
Jan 28, 1982·The New England Journal of Medicine·R HullD McLaughlin
Sep 1, 1981·Southern Medical Journal·R A Knuppel, R A Petrucha
Jul 12, 1980·British Medical Journal·P H Wise, A J Hall
Mar 1, 1981·Clinical Pharmacology and Therapeutics·R J CipolleE Haus
Oct 1, 1995·American Journal of Obstetrics and Gynecology·L R BrancazioS A Laifer

❮ Previous
Next ❯

Citations

Jul 19, 2002·Seminars in Hematology·Susan I O'Shea, Thomas L Ortel
May 5, 2004·MCN. the American Journal of Maternal Child Nursing·Stephanie Colman-Brochu
Jan 5, 2002·Obstetrical & Gynecological Survey·S IeH M Szerlip
Jun 9, 2001·The Journal of Obstetrics and Gynaecology Research·S OzsenerE Ozkinay
Nov 15, 2012·Oxidative Medicine and Cellular Longevity·Isabella AppiahDusko Blagojevic
Jan 5, 2002·Journal of Perinatal Medicine·T WatanabeI Sato
Jan 11, 2007·The Journal of Obstetrics and Gynaecology Research·Vildan AltunayogluRemzi Adnan Akdogan
Feb 27, 2017·BJOG : an International Journal of Obstetrics and Gynaecology·E YefetZ Nachum
Jun 18, 2004·Obstetrics and Gynecology Clinics of North America·Nora M Doyle, Manju Monga
Dec 31, 2003·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·H ChisakaN Yaegashi
Jul 13, 2000·The Laryngoscope·C Ayala, K E Blackwell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

JAMA : the Journal of the American Medical Association
A E Baue
Seminars in Thrombosis and Hemostasis
Jacqueline ConardMeyer-Michel Samama
Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Y S Arkel, D H Ku
Best Practice & Research. Clinical Haematology
Rainer B ZotzRüdiger E Scharf
© 2022 Meta ULC. All rights reserved